PTC Therapeutics (PTCT) PT Raised to $43 at Barclays
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $68.79 -1.85%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Barclays raised its price target on PTC Therapeutics (NASDAQ: PTCT) to $43.00 (from $40.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coinbase (COIN) PT Raised to $212 at Cantor Fitzgerald
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
